Publications
Detailed Information
Risk factors for consequent kidney impairment and differential impact of liver transplantation on renal function
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Jung Pyo | - |
dc.contributor.author | Heo, Nam Ju | - |
dc.contributor.author | Joo, Kwon Wook | - |
dc.contributor.author | Yi, Nam Joon | - |
dc.contributor.author | Moon, Kyung Chul | - |
dc.contributor.author | Kim, Yon Su | - |
dc.contributor.author | Kim, Seong Gyun | - |
dc.contributor.author | Suh, Kyung-Suk | - |
dc.date.accessioned | 2012-05-30T04:37:12Z | - |
dc.date.available | 2012-05-30T04:37:12Z | - |
dc.date.issued | 2010-08 | - |
dc.identifier.citation | NEPHROLOGY DIALYSIS TRANSPLANTATION; Vol.25 8; 2772-2785 | ko_KR |
dc.identifier.issn | 0931-0509 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76616 | - |
dc.description.abstract | Background. Chronic kidney disease (CKD) develops frequently after liver transplantation (LTx), and it is important to identify and correct risk factors that negatively affect kidney function. Risk factors have not been well evaluated in Asian countries where hepatitis B virus (HBV) infection is a dominant cause. Methods. Four hundred thirty-one Korean recipients who underwent LTx between 1997 and 2008 were analysed. CKD was defined as a sustained decrease in estimated glomerular filtration rate (eGFR) of < 60 (mL/min/1.73 m(2)) for at least three consecutive months using an abbreviated Modification in Renal Disease (MDRD) formula. Results. Eighty percent of the patients had HBV-related underlying diseases. The recipients whose pretransplant eGFR had been low (< 30 mL/min/1.73 m(2)) improved their renal function after LTx, but significant functional decline occurred in recipients whose pretransplant eGFR was high (>= 60 mL/min/1.73 m(2)). A multivariate Cox regression analysis revealed that the overall risk of CKD development (eGFR < 60 mL/min/1.73 m(2)) was associated with old age of recipients, cyclosporine, posttransplant acute renal failure (ARF), cause [calcineurin inhibitor (CNI) nephrotoxicity] and severity of posttransplant ARF, low pretransplant eGFR, pretransplant hepatorenal syndrome, pretransplant proteinuria, high Child Pugh score and high Model for End-Stage Renal Disease (MELD) score. Especially in recipients whose pre-operative eGFR was high (>= 60 mL/min/1.73 m(2)), rapid progression of kidney disease was associated with high tacrolimus level, non-HBV disease, posttransplant ARF, cause (CNI nephrotoxicity) and severity of posttransplant ARF and Child-Pugh score. CNI toxicity and focal segmental sclerosis, but not immune-complex disease, were revealed as significant contributors to CKD after LTx in HBV recipients. Conclusion. Judicious use of CNIs should be applied to liver recipients to prevent kidney dysfunction. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | OXFORD UNIV PRESS | ko_KR |
dc.subject | calcineurin inhibitor toxicity | ko_KR |
dc.subject | hepatitis B virus | ko_KR |
dc.subject | kidney biopsy | ko_KR |
dc.subject | liver transplantation | ko_KR |
dc.subject | kidney dysfunction | ko_KR |
dc.title | Risk factors for consequent kidney impairment and differential impact of liver transplantation on renal function | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 이정표 | - |
dc.contributor.AlternativeAuthor | 허남주 | - |
dc.contributor.AlternativeAuthor | 주권욱 | - |
dc.contributor.AlternativeAuthor | 이남준 | - |
dc.contributor.AlternativeAuthor | 서경석 | - |
dc.contributor.AlternativeAuthor | 문경철 | - |
dc.contributor.AlternativeAuthor | 김성균 | - |
dc.contributor.AlternativeAuthor | 김연수 | - |
dc.identifier.doi | 10.1093/ndt/gfq093 | - |
dc.citation.journaltitle | NEPHROLOGY DIALYSIS TRANSPLANTATION | - |
dc.description.citedreference | O`Riordan A, 2009, NEPHROL DIAL TRANSPL, V24, P2276, DOI 10.1093/ndt/gfp112 | - |
dc.description.citedreference | Cicinnati VR, 2007, ALIMENT PHARM THERAP, V26, P1195, DOI 10.1111/j.1365-2036.2007.03466.x | - |
dc.description.citedreference | Tsui JI, 2007, ARCH INTERN MED, V167, P1271 | - |
dc.description.citedreference | De Villa V, 2007, ONCOLOGIST, V12, P1321, DOI 10.1634/theoncologist.12-11-1321 | - |
dc.description.citedreference | IMAI E, 2007, CLIN EXP NEPHROL, V11, P41 | - |
dc.description.citedreference | Kim DY, 2006, TRANSPLANT P, V38, P3663, DOI 10.1016/j.transproceed.2006.10.054 | - |
dc.description.citedreference | O`Riordan A, 2006, NEPHROL DIAL TRANSPL, V21, P2630, DOI 10.1093/ndt/gfl247 | - |
dc.description.citedreference | McGuire BM, 2006, ANN INTERN MED, V144, P735 | - |
dc.description.citedreference | Cabezuelo JB, 2006, KIDNEY INT, V69, P1073, DOI 10.1038/sj.ki.5000216 | - |
dc.description.citedreference | Poge U, 2006, NEPHROL DIAL TRANSPL, V21, P660, DOI 10.1093/ndt/gfi305 | - |
dc.description.citedreference | Guitard J, 2006, RENAL FAILURE, V28, P419, DOI 10.1080/08860220600683607 | - |
dc.description.citedreference | Al Aly Z, 2005, CLIN TRANSPLANT, V19, P683, DOI 10.1111/j.1399-0012.2005.00408.x | - |
dc.description.citedreference | Alessandria C, 2005, HEPATOLOGY, V41, P1282, DOI 10.1002/hep.20687 | - |
dc.description.citedreference | Jafar TH, 2005, J AM SOC NEPHROL, V16, P1413, DOI 10.1681/ASN.2004121100 | - |
dc.description.citedreference | Pillebout E, 2005, AM J TRANSPLANT, V5, P1120, DOI 10.1111/j.1600-6143.2005.00852.x | - |
dc.description.citedreference | Kang YS, 2005, CLIN NEPHROL, V63, P258 | - |
dc.description.citedreference | Zuo L, 2005, AM J KIDNEY DIS, V45, P463, DOI 10.1053/j.ajkd.2004.11.012 | - |
dc.description.citedreference | Sanchez EQ, 2004, TRANSPLANTATION, V78, P1048, DOI 10.1097/01.TP.000013716.95730.5B | - |
dc.description.citedreference | Kim SG, 2004, TRANSPLANT P, V36, P2318, DOI 10.1016/j.transproceed.2004.06.042 | - |
dc.description.citedreference | Velidedeoglu E, 2004, TRANSPLANTATION, V77, P553, DOI 10.1097/01.TP.0000114609.99558.41 | - |
dc.description.citedreference | BELLOMO R, 2004, CRIT CARE, V8, P204 | - |
dc.description.citedreference | Ojo AO, 2003, NEW ENGL J MED, V349, P931 | - |
dc.description.citedreference | Pawarode A, 2003, LIVER TRANSPLANT, V9, P741, DOI 10.1053/jlts.2003.50113 | - |
dc.description.citedreference | Artz MA, 2003, J AM SOC NEPHROL, V14, P1880 | - |
dc.description.citedreference | Khanna A, 2002, KIDNEY INT, V62, P2257 | - |
dc.description.citedreference | Cohen AJ, 2002, LIVER TRANSPLANT, V8, P916, DOI 10.1053/jlts.2002.35668 | - |
dc.description.citedreference | Gonwa TA, 2001, TRANSPLANTATION, V72, P1934 | - |
dc.description.citedreference | Ovuworie CA, 2001, TRANSPLANTATION, V72, P1385 | - |
dc.description.citedreference | Campistol JM, 2000, TRANSPLANTATION, V69, pSS5 | - |
dc.description.citedreference | Arroyo V, 1996, HEPATOLOGY, V23, P164 | - |
dc.description.citedreference | 1994, N ENGL J MED, V331, P1110 | - |
dc.description.citedreference | JOHNSON RJ, 1990, KIDNEY INT, V37, P663 | - |
dc.description.citedreference | LARSEN K, 1972, CLIN CHIM ACTA, V41, P209 | - |
dc.description.tc | 6 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.